Anti-Depressants and Their Link to Adolescent and Teenage Suicide
Two percent of preteens and five percent of adolescents suffer from depression (www.about-teen-depression.com 2004). There are specific signs and symptoms associated with depression, which are helpful in detection of the illness. There are various ways to treat depression, such as medication, group therapy, and/or herbal supplements. There are pros and cons with each treatment, but the worst coincides with the medication suicide. Much research has been conducted, which will be discussed in the paper that has shown a link to antidepressants and suicide. However, there is also evidence that the suicide rate could be decreased with proper diagnosis and early, supervised treatment for depression, especially when dealing with children and adolescents. Introduction
Depression is the newest epidemic sweeping across the world, affecting adults, teenagers, and even children. In fact, surveys have indicated that one in every five teenagers suffer from clinical depression (NMHA 2004). The illness can be found anywhere and appears to make the news each and every day. Depression is a condition that has no preference in its victims, meaning that it will strike people of all ages, races, and backgrounds. However, research has indicated that the onset of depression is now occurring earlier in life compared to past decades (Klerman and Weissman 1989). Knowing this, depression is a condition that needs to be cured immediately. There are many signs and symptoms commonly associated with depression, although most do vary with each individual. Most symptoms include frequent sadness, feelings of hopelessness, decreased activity, persistent boredom and low energy, social isolation, low self esteem, extreme sensitivity, frequents complaints of illness, poor concentration, and thoughts or expression of suicide (www.focusas.com). In order to be diagnosed as suffering from depression, patients must have 2 or more of the above symptoms for at least two weeks that cause severe distress or interfere with daily life (Zoloft 2001). The specific causes of depression are not known. It is suggested that depression is actually a result of a combination of certain factors, such as biological and psychosocial factors (Kendler 1995, www.surgeongeneral.gov 2004). Most likely, depression is the result of a chemical imbalance of neurotransmitters in the brain (NYU 2004). These neurotransmitters, such as serotonin, help regulate mood and positive behavior. While a diagnosis of depression is critical, it is really only half of the battle of fighting the illness. There are still several options for treatment that you must choose from, as well as having to deal with side effects that accompany each treatment. Of all the treatments, antidepressants tend to have the most side effects. Some of the side effects common to all three types of antidepressants are: anxiety, vomiting, confusion, chest pain, blurred vision, irritability, insomnia, sexual dysfunction, weight gain, headache, and nervousness (Cheung et al. 2003, Vanderkooy et al. 2002). Some other, more severe, side effects are difficulty urinating, decreased appetite, heart complications, and suicide (Simon and Stern 2003 - Review). It is the last side effect, suicide, which has recently caused some controversy within the medical field. With recent research showing a correlation between antidepressants and suicide, as well as the FDA ordering warning labels for suicide on antidepressant medication, physicians have to be careful prescribing the drugs, especially to children and adolescents. Statistics show suicide to be the third leading cause of death among 13-19 year olds, with approximately 6000 suicide deaths each year (Dickinson 1999). Because of statistics like this, the National Institute of Mental Health (NIMH) researchers are vying to find interventions to help prevent suicide among children and...
Cited: Birmaher B, Ryan ND, Williamson DE, et al. 1996. Childhood and Adolescent Depression. Journal of American Academy of Child and Adolescent Psychiatry. 35: 1575-1583.
Brown J, Cohen P, Johnson J. G., & Smailes, E. M. 1999. Childhood abuse and neglect: Specificity of effects on adolescent and young adult depression and suicidality. Journal of the American Academy of Child and Adolescent Psychiatry.
Cheung AH, Levitt AJ, Szalai JP. 2003. Impact of Antidepressant side effects on Adolescent quality of life. The Canadian Journal of Psychiatry. 48: 727-734.
Current trends in Treating Adolescent Depression. 2002. . [accessed 18 November 2004].
Depression in Children and Adolescents. 2004. . [accessed 9 December 2004].
Dickinson WP. 1999. Adolescent Depression and Suicide. . [accessed 18 October 2004].
Feng L. 2002. Lexington Clinic East. Doctor/Patient Interview.
Focus Adolescent Services. 2004. . [accessed 9 December 2004].
Findling RL, Reed MD, Blumer JL. 1999. Pharmacological treatment of depression in children and adolescents. Pediatric Drugs. Jul-Sep; 1 (3):161-82.
Hayes D. 2004. Recent Developments in Antidepressant Therapy in Special Populations. American Journal of Managed Care. 10:S179-S185.
Keller MB et al. 2000. A Comparison of Nefazodone, the Cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. The New England Journal of Medicine. 342:1462-1470.
Keller MB, Ryan ND, Strober M et al. 2001. Efficacy of paroxetine in the treatment of adolescent major depression. Journal of American Academy of Child and Adolescent Psychiatry. 40: 762-772.
Kendler KS. 1995. Is seeking treatment for depression predicted by a history of depression in relatives? Psychology Med. 25: 807-814.
Klerman GL & Weissman MM. 1989. Increasing rates of depression. Journal of the American Medical Association.
Kovacs M., Devlin B., Pollock M., Richards C., & Mukerji P. 1997. A controlled family history study of childhood-onset depressive disorder. Archives of General Psychiatry.
Kramer TAM. 2004. Talking Points about antidepressants and suicide. . [accessed 18 October 2004].
Kutcher S. 1998. Affective disorders in children and adolescents: A critical clinically relevant review. Child psychopharmacology
National Mental Health Association
NYU Child Study Center. 2004. About Depressive Disorders. . [accessed 9 December 2004].
Reid LC, and Stewart CA. 2001. How antidepressants work: new perspectives on the pathophysiology of depressive disorder. British Journal of Psychiatry. 178: 299-303.
Renaud J, Axelson D, Birmaher B. 1999. A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents. Drug Safety. Jan; 20 (1):59-75.
Shaffer D, Craft L. 1999. Methods of Adolescent Suicide Prevention. Journal of Clinical Psychiatry. 60: 70-74.
Simon H and Stern T. 2003 – Review. Harvard Medical School.
Strober M, Schmidt-Lackner S, Freeman R et al. 1995. Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 34(6):724-731.
Sullivan, P., Neale, M. C. & Kendler, K. S. 2000. Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry. 157: 1552-1562.
Vanderkooy JD, Kennedy SH, Bagby RM. 2002. Antidepressant side effects in depression patients treated in a naturalistic setting. The Canadian Journal of Psychiatry. 47: 174-180.
Wagner KD, Ambrosini P, Rynn M, et al. 2003. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA. 290: 1033-1041.
Whittington CJ et al. 2004. Selective Serotonin Reuptake Inhibitors in childhood depression. Lancel. 363: 1341-1345.
Zoloft. 2004. . [accessed 21 September 2004].
Please join StudyMode to read the full document